HEADER TRANSCRIPTION 10-SEP-10 3OSW TITLE CRYSTAL STRUCTURE OF PPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH TITLE 2 TETRABROMO-BISPHENOL A (TBBPA) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: PPAR-GAMMA, NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARG, NR1C3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS TRANSCRIPTION, LIGAND BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.LE MAIRE,W.BOURGUET REVDAT 4 21-FEB-24 3OSW 1 REMARK SEQADV REVDAT 3 17-JUL-19 3OSW 1 REMARK REVDAT 2 19-JUN-13 3OSW 1 JRNL VERSN REVDAT 1 25-MAY-11 3OSW 0 JRNL AUTH A.RIU,M.GRIMALDI,A.LE MAIRE,G.BEY,K.PHILLIPS,A.BOULAHTOUF, JRNL AUTH 2 E.PERDU,D.ZALKO,W.BOURGUET,P.BALAGUER JRNL TITL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA IS A TARGET JRNL TITL 2 FOR HALOGENATED ANALOGS OF BISPHENOL A. JRNL REF ENVIRON.HEALTH PERSPECT. V. 119 1227 2011 JRNL REFN ISSN 0091-6765 JRNL PMID 21561829 JRNL DOI 10.1289/EHP.1003328 REMARK 2 REMARK 2 RESOLUTION. 2.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.6_289) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.40 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.020 REMARK 3 COMPLETENESS FOR RANGE (%) : 90.4 REMARK 3 NUMBER OF REFLECTIONS : 19526 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.200 REMARK 3 FREE R VALUE TEST SET COUNT : 821 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.4036 - 4.6323 0.98 3440 169 0.1840 0.2024 REMARK 3 2 4.6323 - 3.6773 0.98 3381 156 0.1534 0.2156 REMARK 3 3 3.6773 - 3.2126 0.95 3294 141 0.1818 0.2523 REMARK 3 4 3.2126 - 2.9189 0.89 3059 126 0.2223 0.3477 REMARK 3 5 2.9189 - 2.7098 0.84 2887 126 0.2435 0.3544 REMARK 3 6 2.7098 - 2.5500 0.77 2644 103 0.2809 0.3518 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.36 REMARK 3 B_SOL : 54.89 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.310 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 49.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.29720 REMARK 3 B22 (A**2) : 10.08650 REMARK 3 B33 (A**2) : -12.38370 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 4.59310 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4167 REMARK 3 ANGLE : 1.144 5628 REMARK 3 CHIRALITY : 0.071 656 REMARK 3 PLANARITY : 0.004 715 REMARK 3 DIHEDRAL : 19.778 1563 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3OSW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-SEP-10. REMARK 100 THE DEPOSITION ID IS D_1000061531. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JUL-10 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9334 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20878 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.550 REMARK 200 RESOLUTION RANGE LOW (A) : 115.536 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : 0.09600 REMARK 200 FOR THE DATA SET : 9.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.43500 REMARK 200 R SYM FOR SHELL (I) : 0.61400 REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.86 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.56 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1M TRI-SODIUM CITRATE, 100 MM HEPES, REMARK 280 3.5% 1,2-PROPANEDIOL, 0.2 MM TBBPA, PH 7.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 46.54450 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.84650 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 46.54450 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 30.84650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 192 REMARK 465 SER A 193 REMARK 465 HIS A 194 REMARK 465 MET A 195 REMARK 465 GLU A 196 REMARK 465 ILE A 197 REMARK 465 SER A 198 REMARK 465 SER A 199 REMARK 465 ASP A 200 REMARK 465 ILE A 201 REMARK 465 ASP A 202 REMARK 465 GLN A 203 REMARK 465 LEU A 204 REMARK 465 LYS A 263 REMARK 465 PHE A 264 REMARK 465 LYS A 265 REMARK 465 HIS A 266 REMARK 465 ILE A 267 REMARK 465 THR A 268 REMARK 465 PRO A 269 REMARK 465 LEU A 270 REMARK 465 GLN A 271 REMARK 465 GLU A 272 REMARK 465 GLN A 273 REMARK 465 GLY B 192 REMARK 465 SER B 193 REMARK 465 HIS B 194 REMARK 465 MET B 195 REMARK 465 GLU B 196 REMARK 465 ILE B 197 REMARK 465 SER B 198 REMARK 465 SER B 199 REMARK 465 ASP B 200 REMARK 465 ILE B 201 REMARK 465 ASP B 202 REMARK 465 GLN B 203 REMARK 465 LEU B 204 REMARK 465 ASN B 205 REMARK 465 PRO B 206 REMARK 465 THR B 241 REMARK 465 THR B 242 REMARK 465 ILE B 262 REMARK 465 LYS B 263 REMARK 465 PHE B 264 REMARK 465 LYS B 265 REMARK 465 HIS B 266 REMARK 465 ILE B 267 REMARK 465 THR B 268 REMARK 465 PRO B 269 REMARK 465 LEU B 270 REMARK 465 GLN B 271 REMARK 465 GLU B 272 REMARK 465 GLN B 273 REMARK 465 SER B 274 REMARK 465 THR B 461 REMARK 465 ASP B 462 REMARK 465 MET B 463 REMARK 465 SER B 464 REMARK 465 LEU B 465 REMARK 465 ASP B 475 REMARK 465 LEU B 476 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 257 CG SD CE REMARK 470 LYS A 275 CG CD CE NZ REMARK 470 GLU A 343 CG CD OE1 OE2 REMARK 470 LYS A 358 CG CD CE NZ REMARK 470 LYS B 240 CG CD CE NZ REMARK 470 LYS B 244 CG CD CE NZ REMARK 470 LYS B 261 CG CD CE NZ REMARK 470 LYS B 358 CG CD CE NZ REMARK 470 GLN B 454 CG CD OE1 NE2 REMARK 470 LYS B 457 CG CD CE NZ REMARK 470 LYS B 458 CG CD CE NZ REMARK 470 LYS B 474 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 240 37.25 -66.98 REMARK 500 LYS A 261 -110.62 -127.78 REMARK 500 LYS A 275 -69.79 -106.31 REMARK 500 GLU A 276 140.85 -178.21 REMARK 500 VAL A 277 -65.43 -27.03 REMARK 500 THR B 238 -82.99 -110.29 REMARK 500 SER B 245 128.59 -28.61 REMARK 500 ASP B 260 30.19 -83.08 REMARK 500 PRO B 304 112.22 -38.69 REMARK 500 SER B 342 74.79 38.36 REMARK 500 ASP B 380 -167.86 -106.07 REMARK 500 LEU B 393 44.21 -81.48 REMARK 500 THR B 459 44.13 -160.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE XDI A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGO A 6128 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3OSI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX REMARK 900 WITH TETRACHLORO-BISPHENOL A (TCBPA) DBREF 3OSW A 196 476 UNP P37231 PPARG_HUMAN 224 504 DBREF 3OSW B 196 476 UNP P37231 PPARG_HUMAN 224 504 SEQADV 3OSW GLY A 192 UNP P37231 EXPRESSION TAG SEQADV 3OSW SER A 193 UNP P37231 EXPRESSION TAG SEQADV 3OSW HIS A 194 UNP P37231 EXPRESSION TAG SEQADV 3OSW MET A 195 UNP P37231 EXPRESSION TAG SEQADV 3OSW GLY B 192 UNP P37231 EXPRESSION TAG SEQADV 3OSW SER B 193 UNP P37231 EXPRESSION TAG SEQADV 3OSW HIS B 194 UNP P37231 EXPRESSION TAG SEQADV 3OSW MET B 195 UNP P37231 EXPRESSION TAG SEQRES 1 A 285 GLY SER HIS MET GLU ILE SER SER ASP ILE ASP GLN LEU SEQRES 2 A 285 ASN PRO GLU SER ALA ASP LEU ARG ALA LEU ALA LYS HIS SEQRES 3 A 285 LEU TYR ASP SER TYR ILE LYS SER PHE PRO LEU THR LYS SEQRES 4 A 285 ALA LYS ALA ARG ALA ILE LEU THR GLY LYS THR THR ASP SEQRES 5 A 285 LYS SER PRO PHE VAL ILE TYR ASP MET ASN SER LEU MET SEQRES 6 A 285 MET GLY GLU ASP LYS ILE LYS PHE LYS HIS ILE THR PRO SEQRES 7 A 285 LEU GLN GLU GLN SER LYS GLU VAL ALA ILE ARG ILE PHE SEQRES 8 A 285 GLN GLY CYS GLN PHE ARG SER VAL GLU ALA VAL GLN GLU SEQRES 9 A 285 ILE THR GLU TYR ALA LYS SER ILE PRO GLY PHE VAL ASN SEQRES 10 A 285 LEU ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY SEQRES 11 A 285 VAL HIS GLU ILE ILE TYR THR MET LEU ALA SER LEU MET SEQRES 12 A 285 ASN LYS ASP GLY VAL LEU ILE SER GLU GLY GLN GLY PHE SEQRES 13 A 285 MET THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO PHE SEQRES 14 A 285 GLY ASP PHE MET GLU PRO LYS PHE GLU PHE ALA VAL LYS SEQRES 15 A 285 PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA ILE SEQRES 16 A 285 PHE ILE ALA VAL ILE ILE LEU SER GLY ASP ARG PRO GLY SEQRES 17 A 285 LEU LEU ASN VAL LYS PRO ILE GLU ASP ILE GLN ASP ASN SEQRES 18 A 285 LEU LEU GLN ALA LEU GLU LEU GLN LEU LYS LEU ASN HIS SEQRES 19 A 285 PRO GLU SER SER GLN LEU PHE ALA LYS LEU LEU GLN LYS SEQRES 20 A 285 MET THR ASP LEU ARG GLN ILE VAL THR GLU HIS VAL GLN SEQRES 21 A 285 LEU LEU GLN VAL ILE LYS LYS THR GLU THR ASP MET SER SEQRES 22 A 285 LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP LEU SEQRES 1 B 285 GLY SER HIS MET GLU ILE SER SER ASP ILE ASP GLN LEU SEQRES 2 B 285 ASN PRO GLU SER ALA ASP LEU ARG ALA LEU ALA LYS HIS SEQRES 3 B 285 LEU TYR ASP SER TYR ILE LYS SER PHE PRO LEU THR LYS SEQRES 4 B 285 ALA LYS ALA ARG ALA ILE LEU THR GLY LYS THR THR ASP SEQRES 5 B 285 LYS SER PRO PHE VAL ILE TYR ASP MET ASN SER LEU MET SEQRES 6 B 285 MET GLY GLU ASP LYS ILE LYS PHE LYS HIS ILE THR PRO SEQRES 7 B 285 LEU GLN GLU GLN SER LYS GLU VAL ALA ILE ARG ILE PHE SEQRES 8 B 285 GLN GLY CYS GLN PHE ARG SER VAL GLU ALA VAL GLN GLU SEQRES 9 B 285 ILE THR GLU TYR ALA LYS SER ILE PRO GLY PHE VAL ASN SEQRES 10 B 285 LEU ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY SEQRES 11 B 285 VAL HIS GLU ILE ILE TYR THR MET LEU ALA SER LEU MET SEQRES 12 B 285 ASN LYS ASP GLY VAL LEU ILE SER GLU GLY GLN GLY PHE SEQRES 13 B 285 MET THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO PHE SEQRES 14 B 285 GLY ASP PHE MET GLU PRO LYS PHE GLU PHE ALA VAL LYS SEQRES 15 B 285 PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA ILE SEQRES 16 B 285 PHE ILE ALA VAL ILE ILE LEU SER GLY ASP ARG PRO GLY SEQRES 17 B 285 LEU LEU ASN VAL LYS PRO ILE GLU ASP ILE GLN ASP ASN SEQRES 18 B 285 LEU LEU GLN ALA LEU GLU LEU GLN LEU LYS LEU ASN HIS SEQRES 19 B 285 PRO GLU SER SER GLN LEU PHE ALA LYS LEU LEU GLN LYS SEQRES 20 B 285 MET THR ASP LEU ARG GLN ILE VAL THR GLU HIS VAL GLN SEQRES 21 B 285 LEU LEU GLN VAL ILE LYS LYS THR GLU THR ASP MET SER SEQRES 22 B 285 LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP LEU HET XDI A 1 21 HET PGO A6128 5 HETNAM XDI 4,4'-PROPANE-2,2-DIYLBIS(2,6-DIBROMOPHENOL) HETNAM PGO S-1,2-PROPANEDIOL FORMUL 3 XDI C15 H12 BR4 O2 FORMUL 4 PGO C3 H8 O2 FORMUL 5 HOH *106(H2 O) HELIX 1 1 ASN A 205 PHE A 226 1 22 HELIX 2 2 THR A 229 GLY A 239 1 11 HELIX 3 3 ASP A 251 ASP A 260 1 10 HELIX 4 4 GLU A 276 SER A 302 1 27 HELIX 5 5 GLY A 305 LEU A 309 5 5 HELIX 6 6 ASP A 310 LEU A 333 1 24 HELIX 7 7 SER A 342 GLY A 344 5 3 HELIX 8 8 ARG A 350 SER A 355 1 6 HELIX 9 9 PRO A 359 PHE A 363 5 5 HELIX 10 10 MET A 364 ALA A 376 1 13 HELIX 11 11 ASP A 380 LEU A 393 1 14 HELIX 12 12 ASN A 402 HIS A 425 1 24 HELIX 13 13 GLN A 430 LYS A 438 1 9 HELIX 14 14 LYS A 438 GLU A 460 1 23 HELIX 15 15 HIS A 466 LYS A 474 1 9 HELIX 16 16 SER B 208 PHE B 226 1 19 HELIX 17 17 THR B 229 GLY B 239 1 11 HELIX 18 18 ASP B 251 GLU B 259 1 9 HELIX 19 19 GLU B 276 LYS B 301 1 26 HELIX 20 20 ASP B 310 LEU B 333 1 24 HELIX 21 21 ARG B 350 SER B 355 1 6 HELIX 22 22 PRO B 359 PHE B 363 5 5 HELIX 23 23 MET B 364 ALA B 376 1 13 HELIX 24 24 ASP B 380 LEU B 393 1 14 HELIX 25 25 ASN B 402 HIS B 425 1 24 HELIX 26 26 GLN B 430 LYS B 458 1 29 HELIX 27 27 HIS B 466 LYS B 474 1 9 SHEET 1 A 4 PHE A 247 ILE A 249 0 SHEET 2 A 4 GLY A 346 THR A 349 1 O PHE A 347 N ILE A 249 SHEET 3 A 4 GLY A 338 ILE A 341 -1 N VAL A 339 O MET A 348 SHEET 4 A 4 MET A 334 ASN A 335 -1 N ASN A 335 O GLY A 338 SHEET 1 B 4 PHE B 247 ILE B 249 0 SHEET 2 B 4 GLY B 346 THR B 349 1 O PHE B 347 N ILE B 249 SHEET 3 B 4 GLY B 338 ILE B 341 -1 N VAL B 339 O MET B 348 SHEET 4 B 4 MET B 334 ASN B 335 -1 N ASN B 335 O GLY B 338 CISPEP 1 LYS A 358 PRO A 359 0 7.85 CISPEP 2 LYS B 358 PRO B 359 0 1.21 SITE 1 AC1 12 HOH A 22 HOH A 40 CYS A 285 ARG A 288 SITE 2 AC1 12 SER A 289 LEU A 330 VAL A 339 LEU A 340 SITE 3 AC1 12 ILE A 341 SER A 342 GLU A 343 MET A 364 SITE 1 AC2 1 HOH A 49 CRYST1 93.089 61.693 118.458 90.00 102.75 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010742 0.000000 0.002431 0.00000 SCALE2 0.000000 0.016209 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008655 0.00000